Harnessing Polymicrobial Interactions in the Catheterized Urinary Tract to Identify Novel Inhibitors of Proteus Mirabilis Urease Activity.
Identifying novel compounds that decrease P. mirabilis urease activity, determining their mechanism of action, and conducting pre-clinical assessment of therapeutic potential.